CiteWeb id: 20110000063

CiteWeb score: 2549

DOI: 10.1093/eurheartj/ehr236

ABOARD: Angioplasty to Blunt the Rise of Troponin in Acute Coronary Syndromes Randomized for an Immediate or Delayed InterventionACC: American College of CardiologyACE: angiotensin-converting enzymeACS: acute coronary syndromesACT: activated clotting timeACUITY: Acute Catheterization and Urgent Intervention Triage strategYAF: atrial fibrillationAHA: American Heart AssociationAPPRAISE: Apixaban for Prevention of Acute Ischemic EventsaPTT: activated partial thromboplastin timeARB: angiotensin receptor blockerARC: Academic Research ConsortiumATLAS: Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Aspirin With or Without Thienopyridine Therapy in Subjects with Acute Coronary SyndromeBARI-2D: Bypass Angioplasty Revascularization Investigation 2 DiabetesBMS: bare-metal stentBNP: brain natriuretic peptideCABG: coronary bypass graftCAD: coronary artery diseaseCI: confidence intervalCK: creatinine kinaseCKD: chronic kidney diseaseCK-MB: creatinine kinase myocardial bandCOX: cyclo-oxygenaseCMR: cardiac magnetic resonanceCOMMIT: Clopidogrel and Metoprolol in Myocardial Infarction TrialCPG: Committee for Practice GuidelinesCrCl: creatinine clearanceCRP: C-reactive proteinCRUSADE: Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelinesCT: computed tomographyCURE: Clopidogrel in Unstable Angina to Prevent Recurrent EventsCURRENT: Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EventsCYP: cytochrome P450DAPT: dual (oral) antiplatelet therapyDAVIT: Danish Study Group on Verapamil in Myocardial Infarction TrialDES: drug-eluting stentDTI: direct thrombin inhibitorDIGAMI: Diabetes, Insulin Glucose Infusion in Acute Myocardial InfarctionEARLY-ACS: Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary SyndromeECG: electrocardiogrameGFR: estimated glomerular filtration rateELISA: Early or Late Intervention in unStable AnginaESC: European Society of CardiologyFactor Xa: activated factor XFFR: fractional flow reserveFRISC: Fragmin during Instability in Coronary Artery DiseaseGP IIb/IIIa: glycoprotein IIb/IIIaGRACE: Global Registry of Acute Coronary EventsHINT: Holland Interuniversity Nifedipine/Metoprolol TrialHIT: heparin-induced thrombocytopeniaHORIZONS: Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial InfarctionHR: hazard ratiohsCRP: high-sensitivity C-reactive proteinICTUS: Invasive vs. Conservative Treatment in Unstable coronary SyndromesINR: international normalized ratioINTERACT: Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome TreatmentISAR-COOL: Intracoronary Stenting With Antithrombotic Regimen Cooling OffISAR-REACT: Intracoronary stenting and Antithrombotic Regimen- Rapid Early Action for Coronary Treatmenti.v.: intravenousLDL-C: low-density lipoprotein cholesterolLMWH: low molecular weight heparinLV: left ventricularLVEF: left ventricular ejection fractionMB: myocardial bandMDRD: Modification of Diet in Renal DiseaseMERLIN: Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary SyndromesMI: myocardial infarctionMINAP: Myocardial Infarction National Audit ProjectMRI: magnetic resonance imagingNNT: numbers needed to treatNSAID: non-steroidal anti-inflammatory drugNSTE-ACS: non-ST-elevation acute coronary syndromesNSTEMI: non-ST-elevation myocardial infarctionNT-proBNP: N-terminal prohormone brain natriuretic peptideOASIS: Organization to Assess Strategies for Ischaemic SyndromesOPTIMA: Optimal Timing of PCI in Unstable AnginaOR: odds ratioPCI: percutaneous coronary interventionPENTUA: Pentasaccharide in Unstable AnginaPLATO: PLATelet inhibition and patient OutcomesPURSUIT: Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyRCT: randomized controlled trialRE-DEEM: Randomized Dabigatran Etexilate Dose Finding Study In Patients With Acute Coronary Syndromes (ACS) Post Index Event With Additional Risk Factors For Cardiovascular Complications Also Receiving Aspirin And ClopidogrelREPLACE-2: Randomized Evaluation of PCI Linking Angiomax to reduced Clinical EventsRIKS-HIA: Register of Information and Knowledge about Swedish Heart Intensive care AdmissionsRITA: Research Group in Instability in Coronary Artery Disease trialRR: relative riskRRR: relative risk reductionSTE-ACS: ST-elevation acute coronary syndromeSTEMI: ST-elevation myocardial infarctionSYNERGY: Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors trialSYNTAX: SYNergy between percutaneous coronary intervention with TAXus and cardiac surgeryTACTICS: Treat angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative StrategyTARGET: Do Tirofiban and ReoPro Give Similar Efficacy Outcomes TrialTIMACS: Timing of Intervention in Patients with Acute Coronary SyndromesTIMI: Thrombolysis In Myocardial InfarctionTRITON: TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel–Thrombolysis In Myocardial InfarctionUFH: unfractionated heparinVKA: vitamin K antagonistVTE: venous thrombo-embolismGuidelines summarize and evaluate all available evidence, at the time of the writing process, on a particular issue with the aim of assisting physicians in selecting the best management strategies for an individual patient, with a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines are no substitutes but are complements for textbooks and cover the European Society of Cardiology (ESC) Core Curriculum topics. Guidelines and recommendations should help the physicians to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible physician(s).A great number of Guidelines have been issued in recent years by the ESC as well as by other societies and organizations. Because of the impact …

The publication "ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation" is placed in the Top 10000 of the best publications in CiteWeb. Also in the category Medicine it is included to the Top 1000. Additionally, the publicaiton "ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation" is placed in the Top 100 among other scientific works published in 2011.
Links to full text of the publication: